Accretion Pharmaceuticals

Ahmedabad, India Founded: 2012 • Age: 14 yrs
Tablets, capsules, and oral liquids are manufactured for therapeutic categories.
Annual revenue $599,654 Latest available
Total funding - Funding intelligence
Employees 1 Tracked headcount
Investors - Known backers
Products 3 Services tracked
Competitors 9 Brand Intelligence

About Accretion Pharmaceuticals

Accretion Pharmaceuticals is a company based in Ahmedabad (India) founded in 2012 by Harshad Rathod and Mayur Sojitra. The company has 1 employees as of October 23, 2024. Accretion Pharmaceuticals offers products and services including Pharmaceutical Products, Nutraceuticals, and Ayurveda Products. Accretion Pharmaceuticals operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

  • Headquarter Ahmedabad, India
  • Employees 1 as on 23 Oct, 2024
  • Founders Harshad Rathod, Mayur Sojitra
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Accretion Pharmaceuticals Ltd.
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $599.65 K (USD)
    72.72
    as on Mar 31, 2024
  • Net Profit
    $84.5 K (USD)
    260.28
    as on Mar 31, 2024
  • EBITDA
    $143.4 K (USD)
    81.39
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    1

    as on Oct 23, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Accretion Pharmaceuticals

Accretion Pharmaceuticals is a publicly listed company on the NSE with ticker symbol ACCPL in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: ACCPL · Sector: Health technology · India

Products & Services of Accretion Pharmaceuticals

Accretion Pharmaceuticals offers a comprehensive portfolio of products and services, including Pharmaceutical Products, Nutraceuticals, and Ayurveda Products.

Product name locked
Category locked
Primary

High-quality drugs and formulations for medical use

Product name locked
Category locked
Locked

Nutritional products supporting wellness and health

Product name locked
Category locked
Locked

Herbal formulations based on Ayurveda for natural health

Funding Insights of Accretion Pharmaceuticals

Premium access

Detailed funding history for Accretion Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Accretion Pharmaceuticals

Investments
Premium access

Investment portfolio details for Accretion Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Accretion Pharmaceuticals

Premium access

Detailed financials for Accretion Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Accretion Pharmaceuticals Comparisons

Accretion Pharmaceuticals Primary company
Description
Tablets, capsules, and oral liquids are manufactured for the...
Location
Ahmedabad, India
Founded Year
2012
Annual Revenue
$599.65 K (USD)
Net Profit
$84.5 K (USD)
EBITDA
$143.4 K (USD)
Employees
1
As of 2024
Premium access

Peer comparison for Accretion Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Accretion Pharmaceuticals

Accretion Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Contract development and manufacturing organization for proprietary and generic drugs
Locked Locked Locked
CDMO focusing on spectrum of dosage forms and therapeutic segments
Locked Locked Locked
Company offering a suite of R&D and manufacturing services for small molecules and generics
Locked Locked Locked
Pharmaceutical development and manufacturing services are offered contractually.
Locked Locked Locked
CDMO with a focus on early phase drug product development
Locked Locked Locked
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed competitors of Accretion Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Accretion Pharmaceuticals

Premium access

Complete news archive for Accretion Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Accretion Pharmaceuticals

Accretion Pharmaceuticals was founded in 2012.

Accretion Pharmaceuticals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

As of Oct 23, 2024, the latest employee count at Accretion Pharmaceuticals is 1.

Annual revenue of Accretion Pharmaceuticals is $599.65K as on Mar 31, 2024.

Accretion Pharmaceuticals was established in 2012 in Ahmedabad, India. Tablets, capsules, and oral liquids are produced across various therapeutic categories, including analgesics, antibiotics, antidiabetics, cardiovascular drugs, gastrointestinal treatments, vitamins, and minerals. Operations focus on pharmaceutical manufacturing within the healthcare sector, with distribution centered in India. Leadership includes co-founders Harshad Rathod and Mayur Sojitra.

Accretion Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Accretion Pharmaceuticals offers Pharmaceutical Products, Nutraceuticals, and Ayurveda Products.

Yes, Accretion Pharmaceuticals is publicly traded on NSE under the ticker symbol ACCPL.

The ticker symbol of Accretion Pharmaceuticals is ACCPL on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available